SCHEMBL7387979

SCHEMBL7387979

O=[PH](O)OCC(Cc1ccccc1)(Cc1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
FDPS P14324 1/20 0.36
KCNA5 P22460 1/20 0.35
CYP3A4 P08684 1/20 0.35
RECQL P46063 1/20 0.35
KIF11 P52732 2/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.33
PTPN1 P18031 1/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A2 P23975 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
KCNH2 Q12809 2/20 0.32
MRGPRX2 Q96LB1 1/20 0.32
CHRM3 P20309 1/20 0.32
HRH2 P25021 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387975 0.86 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19SMN1; SMN2HIF1A
SCHEMBL9312889 0.84 PTPN1 (0.40) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL9313695 0.78 ACP3 (0.40) SMN1; SMN2HIF1AKIF11
SCHEMBL11020720 0.74 CYP1A2 (0.39) CYP1A2CYP2C9CYP2C19HIF1AMAPK1
SCHEMBL9063882 0.73 CYP1A2 (0.58) CYP1A2CYP2C9CYP2C19SMN1; SMN2HIF1A
SCHEMBL27963095 0.72 CYP2C9 (0.46) CYP1A2CYP2C9CYP2C19SMN1; SMN2HIF1A
SCHEMBL9312893 0.71 PTPN1 (0.39) CYP1A2SMN1; SMN2CYP3A4KIF11PTPN1
SCHEMBL698616 0.70 TSHR (0.48) CYP1A2CYP2C19SMN1; SMN2HIF1AMAPK1
SCHEMBL7095560 0.70 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19SMN1; SMN2HIF1A
SCHEMBL19744359 0.70 TDP1 (0.39) SMN1; SMN2MAPK1TAAR1HTR2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3173898-A None JP disclosed
US-5389612-A Treating infections caused by clostridium histolyticum and pseudomonas aeruginosa; enzyme inhibitors COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1995-02-14 US disclosed
EP-0565450-A1 Use of peptide derivatives for the manufacture of medicaments inhibiting endopeptidases 24.15 and 24.16 COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1993-10-13 EP disclosed
JP-H03173898-A NEW PHOSPHONIC PEPTIDE DERIVATIVE USEFUL AS INHIBITOR OF BACTERIAL COLLAGENASE COMMISS ENERG ATOM 1991-07-29 JP disclosed